Injectable Anaerobic Hydrogel Loading Clostridium Butyricum in Colorectal Cancer in Mice

An oxygen-depleting hydrogel protected Clostridium butyricum under aerobic tumor conditions, allowing the bacteria to continuously generate hydrogen and antitumor metabolites that disrupted cancer cell redox balance, impaired mitochondrial respiration, and suppressed tumor growth.

An injectable gel containing hydrogen-producing bacteria successfully delivered sustained hydrogen therapy to colorectal tumors in animal studies, suppressing tumor growth by disrupting cancer cell energy production.

Researchers developed a special gel containing bacteria that produce hydrogen gas, designed to be injected directly into colorectal tumors. The gel creates an oxygen-free environment that keeps the bacteria alive even in oxygen-rich areas of tumors. In laboratory and animal studies, the hydrogen gas and bacterial byproducts together disrupted cancer cells' energy production and triggered cell death, slowing tumor growth.

This is early-stage research conducted in laboratory and animal models only—not human studies. While it suggests hydrogen gas may have anti-cancer potential when delivered directly to tumors, it does not demonstrate safety or effectiveness in people. Much more research would be needed before this approach could be considered for human use.

Hydrogen (H2), a non-toxic therapeutic gas, exerts antitumor effects by disrupting intracellular redox homeostasis and inducing mitochondrial dysfunction. The high diffusibility of H2, as well as its storage difficulties, hinders its sustained release at tumor sites. Thus, the therapeutic effect…

Read the full abstract on PubMed